Long-term safety, tolerability, and efficacy of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder.

@article{Homma2008LongtermST,
  title={Long-term safety, tolerability, and efficacy of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder.},
  author={Yukio Homma and Osamu Yamaguchi},
  journal={International journal of urology : official journal of the Japanese Urological Association},
  year={2008},
  volume={15 11},
  pages={986-91}
}
OBJECTIVES To evaluate the long-term safety, tolerability, and efficacy of imidafenacin, a novel anti-muscarinic agent, in Japanese patients with overactive bladder. METHODS Men and women who had overactive bladder symptoms were enrolled for open-label treatment with 0.1 mg of imidafenacin twice daily for 52 weeks; the safety and efficacy of the treatment regimen were assessed. RESULTS A total of 478 patients received the treatment and 376 patients completed the 52-week program… CONTINUE READING